Sirolimus Treatment for Refractory PRCA
NCT03364764
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
64
Enrollment
OTHER
Sponsor class
Conditions
Pure Red Cell Aplasia
Interventions
DRUG:
Sirolimus
Sponsor
Bing Han